Skip to content

Evaluation of the effects after using different mouthwashes

Evaluation of the effects of 0.12% chlorexidine and blue®m mouthwash in patients with gingivitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-8dfz66h
Enrollment
Unknown
Registered
2021-09-03
Start date
2019-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Interventions

Two weeks before the beginning of the study, all patients received periodontal scaling and corono-radicular polishing and were instructed to not eat food or drinks that could cause great stainings of
D01.268.185.550

Sponsors

Fundação de Assistência e Educação - FAESA
Lead Sponsor
Fundação de Assistência e Educação - FAESA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Present more than 24 teeth and generalized gingivitis; Absence of periodontal pockets with depth greater than 4mm; No interproximal loss greater than 2mm.

Exclusion criteria

Exclusion criteria: Use of orthodontic appliance; Treatment of antibiotics in the last 3 months; Smokers, pregnant and nursing women.

Design outcomes

Primary

MeasureTime frame
Evaluate staining of teeth and restorations using different types of mouthwashes (Chlorhexidine 0.12% and Blue®M). All patients were photographed before and after treatment so that photographic analyzes could be performed, in addition, the area of staining of the teeth was evaluated with the ImageJ software. It was observed that 0.12% chlorhexidine had significantly greater staining than Blue®M.;Clinical analyzes (marginal bleeding index and bacterial biofilm index) were performed to determine whether the patient had gingivitis or not, before and after treatment with the mouthwashes. It was found that both mouthwashes were efficient in the treatment of gingivitis, with no significant difference between the products.

Secondary

MeasureTime frame
No secondary outcomes.

Countries

Brazil

Contacts

Public ContactFausto Borges Filho
faustofrizzera@yahoo.com.br+55-027-999452339

Outcome results

None listed

Source: REBEC (via WHO ICTRP)